Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

BUY
$79.22 - $105.37 $3.98 Million - $5.29 Million
50,249 Added 31.08%
211,931 $21.6 Million
Q1 2023

May 02, 2023

BUY
$30.85 - $93.17 $4.99 Million - $15.1 Million
161,682 New
161,682 $14.7 Million
Q3 2022

Nov 02, 2022

BUY
$19.41 - $36.49 $12,635 - $23,754
651 Added 5.9%
11,690 $294,000
Q2 2022

Aug 01, 2022

SELL
$20.71 - $36.5 $289 - $511
-14 Reduced 0.13%
11,039 $335,000
Q1 2022

May 04, 2022

SELL
$24.12 - $39.6 $1,760 - $2,890
-73 Reduced 0.66%
11,053 $281,000
Q4 2021

Feb 07, 2022

SELL
$25.61 - $110.96 $37,877 - $164,109
-1,479 Reduced 11.73%
11,126 $293,000
Q3 2021

Nov 02, 2021

SELL
$100.0 - $143.02 $13,200 - $18,878
-132 Reduced 1.04%
12,605 $1.27 Million
Q2 2021

Aug 03, 2021

SELL
$78.27 - $151.29 $45,161 - $87,294
-577 Reduced 4.33%
12,737 $1.8 Million
Q1 2021

May 04, 2021

SELL
$94.25 - $132.81 $62,016 - $87,388
-658 Reduced 4.71%
13,314 $1.33 Million
Q4 2020

Feb 01, 2021

SELL
$102.03 - $184.62 $163,452 - $295,761
-1,602 Reduced 10.29%
13,972 $1.73 Million
Q3 2020

Nov 09, 2020

SELL
$93.53 - $163.34 $547,150 - $955,539
-5,850 Reduced 27.31%
15,574 $1.52 Million
Q2 2020

Aug 07, 2020

BUY
$126.3 - $176.56 $37,637 - $52,614
298 Added 1.41%
21,424 $3.34 Million
Q1 2020

May 04, 2020

SELL
$124.16 - $247.74 $47,056 - $93,893
-379 Reduced 1.76%
21,126 $3.05 Million
Q4 2019

Feb 06, 2020

BUY
$74.57 - $217.92 $76,881 - $224,675
1,031 Added 5.04%
21,505 $4.4 Million
Q4 2019

Feb 04, 2020

SELL
$74.57 - $217.92 $512,146 - $1.5 Million
-6,868 Reduced 25.12%
20,474 $4.48 Million
Q3 2019

Nov 12, 2019

BUY
$71.26 - $95.75 $1.9 Million - $2.56 Million
26,697 Added 4139.07%
27,342 $2.2 Million
Q2 2019

Aug 15, 2019

SELL
$77.72 - $94.35 $25,025 - $30,380
-322 Reduced 33.3%
645 $61,000
Q4 2018

Feb 05, 2019

SELL
$48.76 - $76.44 $8,971 - $14,064
-184 Reduced 15.99%
967 $54,000
Q3 2018

Nov 01, 2018

BUY
$35.64 - $92.06 $5,381 - $13,901
151 Added 15.1%
1,151 $94,000
Q1 2018

May 04, 2018

SELL
$20.0 - $30.19 $473,400 - $714,597
-23,670 Reduced 95.95%
1,000 $21,000
Q4 2017

Feb 01, 2018

BUY
$22.39 - $33.27 $60,229 - $89,496
2,690 Added 12.24%
24,670 $698,000
Q3 2017

Oct 27, 2017

BUY
$26.29 - $31.88 $24,975 - $30,286
950 Added 4.52%
21,980 $683,000
Q2 2017

Aug 07, 2017

BUY
N/A
21,030
21,030 $665,000

Others Institutions Holding RETA

About REATA PHARMACEUTICALS INC


  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.